Immunotherapy after bladder cancer surgery may reduce recurrence: Study

Read more about Immunotherapy after bladder cancer surgery may reduce recurrence: Study on Business Standard. Researchers at the Memorial Sloan Kettering Cancer Center found that patients who received nivolumab after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence

Related Keywords

,Drug Administration ,Memorial Sloan Kettering Cancer Center ,New England Journal ,Cancer ,Clinical Medicine ,Drugs ,Bristol Myers Squibb ,Bladder Cancer ,Nivolumab ,Mask ,Urinary Bladder ,Davida Scheinberg ,Treatment Of Lung Cancer ,Herapies For Advanced Metastatic Bladder ,நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் மையம் ,புதியது இங்கிலாந்து இதழ் ,புற்றுநோய் ,விரிப்புகள் ,ஸ்க் ,